(4).
The relationship of these agglutinogens to immunity induced by pertussis vaccines is not clear. Work with purified fractions of B. pertussis has indicated that at least some of the agglutinogens are separated from the antigen that is responsible for immunity in the mouse protection test of Kendrick et al. (10) . Moreover, no difference in mouse-protective activity has been demonstrated among vaccines prepared from cultures possessing different combinations of agglutinogens (2, 7, 8, 24) . These observations indicate that the specific agglutinogens 2, 3, 4, 5, and 6 do not play a significant role in active immunization of mice. This cannot be said with certainty of agglutinogen 1, because this antigen is present in all smooth strains of B. pertussis (5) , and definite separation of this agglutinogen and mouse-protective antigen (PA) has not been reported.
Recent epidemiological findings (3, 17) and results of passive mouse protection tests (18, ' 19 ) have suggested to the authors that typespecific immunity to B. pertussis may exist. These studies have emphasized the need for more precise definition of the role of the agglutinogens in immunity to B. pertussis.
We previously showed that the histaminesensitizing factor (HSF) and PA can be found in the same fractions obtained from starchblock electrophoresis (15) , and that the physical and chemical properties of PA and HSF are similar if not identical. However, PA or HSF has not been obtained in a pure form. Because of the uncertainty regarding the role of agglutinogen I in protection and the unavailability of a pure preparation of PA, it was important to determine whether these antigens could be separated.
MATERIALS AND METHODS Serotype I B. pertussis strain 353/Z and serotype 1, 3 strain J20 were obtained from N. Preston, University of Manchester, Manchester, England (17 Acetone-dried cells, SE, and MgSO4-precipitated HSF were prepared as previously described (16a). The sediments after extraction of SE and after precipitation of HSF by MgSO6 were dialyzed against distilled water and lyophilized.
Endotoxin was prepared by the trichloroacetic acid extraction method of Boivin as described by Kabat (9) .
Mouse protection tests were performed as previously described (16) , by using intracranial (ic) challenge with B. pertussis 2753. Histamine sensitization tests were performed by giving the sensitizing materials iv and challenging the mice intraperitoneally (ip) 24 hr later with 0.5 mg of histamine base given as histamine diphosphate (14) .
Agglutinin absorption tests to determine amounts of agglutinogen present in various fractions were performed as follows. Saline dilutions of antigen were mixed with an equal volume of antiserum diluted to a concentration twice its plate agglutination titer, and the mixture was incubated for 15 min at room temperature, mixed again, and allowed to incubate for an additional 15 min. The mixture was centrifuged, and the absorbed serum was tested for agglutinins as described above. Nonspecific absorption of antibodies was controlled by absorbing the sera with SE prepared from B. bronchiseptica strain 22067, and specific absorption was controlled by absorbing with SE from strain 353/Z. Consistently, 0.25 to 0.5 mg of SE from strain 353/Z absorbed antibodies from 1 ml of diluted serum.
Starch-block electrophoresis was performed as described previously (15) . The starch block (50 by 9.5 by 1.2 cm) was made in phosphate buffer (pH 6.2; A = 0.02). SE (100 mg) was applied at the center of the block. Electrophoresis, performed at 6 to 10 ma and 200 v, was carried out at 4 C for 40 hr. The block was cut into 25, 2-cm strips, each strip was then eluted with the phosphate buffer, and the eluates were dialyzed against water and lyophilized. RESULTS SE from B. pertussis 353/Z was fractionated by starch-block electrophoresis, and the fractions were subsequently tested by agar diffusion. This SE exhibited an antigenic complexity similar to that of SE prepared from another strain of B. pertussis (15) . Sixteen different bands developed with the anti-B. pertussis serum (Fig. 1) . Only four bands developed when factor I antiserum was employed (Fig. 2) . One band was located at fractions 7 and 8, a second in fraction 10, and a third in fractions 9 to 15 which corresponded closely to the distribution of agglutinogen 1. A fourth was a weak band close to the sample application in fractions 14 and 15 (this may be due to protective antigen).
The relationships of optical density, agglutinogen I activity, mouse-protecting activity, and histamine-sensitizing activity of the various starch-block electrophoresis fractions are shown in Fig. 3 .
The HSF and PA activities remained near the point of application in fractions 13 and 14. Some PA was also found in fraction 15. Most of the factor I agglutinin-absorbing activity migrated toward the cathode and was found in fractions 8 to 11. Also, some of this activity was usually found close to the origin (fractions 13 to 16; Fig. 3 ). This distribution of agglutinogen 1, HSF, and PA occurred in many different electrophoretic runs; only once was all of the agglutinogen activity found in the region of fractions 8 to 11. Fractions 9 to 15 produced a line of precipitate which coincided with agglutinogen I activity. Fraction 10 had, in addition, another unidentified band (Fig. 2) .
Starch-block electrophoresis was also done with SE from B. pertussis strains 04965 (serotype 1) and J20 (serotypes 1, 3). SE from strain 04965 gave similar results to those obtained with strain 353/Z SE. With J20, it was found that agglutinogen 3 did not move from the point of application, whereas agglutinogen I had a distribution similar to that found with SE from strains 353/Z and 04965.
Agglutinogen 
DISCUSSION
Since the development of the mouse protection test by Kendrick and co-workers (10) for the evaluation of pertussis vaccines, efforts have been made to determine which component of the B. pertussis cell is responsible for the induction of immunity in children. Heat-labile toxin (22) , agglutinogens (17) , and hemagglutinin (11) were considered important in induction of specific immunity to whooping cough. Studies published by the British Medical Research Council (12) showed a direct correlation between PA activity of pertussis vaccines and their effectiveness in production of immunity to whooping cough. Since this report, it has been assumed that the antigen measured by the mouse protection test is identical to that responsible for immunization of children. With this mouse protection test, heat-labile toxin, heat-stable toxin, some "agglutinogen" preparations, and hemagglutinin have failed to produce active immunity (13, 20) .
The substance responsible for mouse protection has been suspected to be a lipoprotein, the activity of which is destroyed by heating at 80 C for 30 min; it is polydispersed and can be Q2Fu--_1 t3 (13, 14) . This substance is different from some agglutinogens, heat-labile toxin, hemagglutinin, and endotoxin (13) . The results presented here show that mouse-protective activity of purified fractions is not due to agglutinogen 1. Most agglutinogen I can be separated by starch-block electrophoresis from HSF and protective antigen. This isolated agglutinogen was not serologically related to PA, HSF, or endotoxin from B. pertussis and did not protect mice or sensitize them to histamine. Preston has indicated that agglutinogens 1, 2, and 3 are important in protecting children against whooping cough (17) (18) (19) 
